Davis Hugh M. bought ACRS
December 2, 2025 · Form 4 insider transaction
Davis Hugh M. bought 26,750 shares of Aclaris Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,750
Price
N/A
Total value
N/A
InsiderDavis Hugh M.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 2, 2025
Filing dateDecember 4, 2025
Shares owned after26,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.